Protocol No
OTO-IIT-JOHNSTON-FLUTTER
Staff Member
Nikki Johnston
Phase
II
Summary
This project is being done to determine if 12 week treatment with fosamprenavir resolves symptoms and endoscopic findings of Laryngopharyngeal Reflux (LPR). This study will also evaluate a new daily LPR symptom questionnaire to determine its usefulness for future trials of new therapies for LPR.
Objective
Fosamprenavir for Laryngopharyngeal Upper Airway Tissue Treatment and Enzyme Reduction
Status
OPEN TO ACCRUAL
Categories
ClinicalTrials.gov